Puma Biotechnology's P 2 SUMMIT trial results of neratinib in HER2-Mutant, metastatic cervical cancers were published online in Gynecologic Oncology.
Puma Biotechnology's P 2 SUMMIT trial results of neratinib in HER2-Mutant, metastatic cervical cancers were published online in Gynecologic Oncology.
LOOKING forward to hitting the gym again? You won’t need to wait for long now, as gyms are officially re-opening tomorrow, July 25. It’s also an opportunity to upgrade your workout styl…
The company is expected to report second-quarter results on Tuesday. Raymond James analyst Joseph Altobello said Covid-19 will have a significant impact on results.
Puma Biotechnology will release its financial results and host a conference call after the close of U.S. markets on August 6, 2020.
These trendy styles are almost too cool for school.
Sen. Josh Hawley called out Adidas, Nike and Puma.
Give a modern twist to your golfing gear with one of these practical yet stylish pairs
Análisis de Acciones por Salva Fuster cubriendo: Intel Corporation, Puma SE. Lea los Análisis de Acciones de Salva Fuster en Investing.com.
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 16) * AC Immune SA (NASDAQ: ACIU) ( announced clinical t
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tiziana Life
MERIAN GLOBAL INVESTORS UK Ltd acquired a new stake in Puma Biotechnology Inc (NASDAQ:PBYI) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutiona
Puma Biotechnology's licensing partner Specialised Therapeutics Asia received authorization to market NERLYNX in Malaysia.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE